Intravenous fat-tolerance test in ischaemic heart disease and peripheral vascular disease

Insights

Patients with vascular disease have slower triglyceride clearance and higher lipid levels. This suggests hypertriglyceridemia in these patients may stem from impaired clearance or overproduction of triglycerides.

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Vascular Biology

Background:

  • Cardiovascular diseases, including ischemic heart disease and peripheral vascular disease, are often associated with lipid metabolism abnormalities.
  • Understanding triglyceride kinetics is crucial for assessing cardiovascular risk.

Purpose of the Study:

  • To investigate differences in exogenous triglyceride metabolism and serum lipid profiles between healthy individuals and patients with vascular diseases.
  • To explore the potential mechanisms underlying hypertriglyceridemia in cardiovascular patients.

Main Methods:

  • Conducted intravenous fat-tolerance tests and measured serum lipid and lipoprotein levels in 93 normal subjects, 51 patients with ischemic heart disease, and 30 patients with peripheral vascular disease.
  • Assessed the fractional turnover rate of exogenous triglyceride and fasting serum concentrations of triglyceride and cholesterol.

Main Results:

  • Patients with ischemic heart disease and peripheral vascular disease exhibited significantly slower fractional triglyceride turnover rates compared to normal subjects.
  • Both vascular disease groups showed higher serum triglyceride and cholesterol concentrations than controls.
  • 35% of patients had subnormal triglyceride clearance, and 32% had hypertriglyceridemia; 27% were hypercholesterolemic.

Conclusions:

  • Impaired triglyceride clearance and/or overproduction contribute to hypertriglyceridemia in patients with vascular diseases.
  • The findings suggest distinct pathophysiological mechanisms for hypertriglyceridemia in cardiovascular patients, potentially aiding in targeted therapeutic strategies.